MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.

Melinda Rezeli, Ákos Végvári, Jan Ottervald, Tomas Olsson, Thomas Laurell, György Marko-Varga

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

15 Citeringar (SciVal)

Sammanfattning

As a proof-of-principle study, a multiple reaction monitoring (MRM) assay was developed for quantitation of proteotypic peptides, representing seven plasma proteins associated with inflammation (complement components and C-reactive protein). The assay development and the sample analysis were performed on a linear ion trap mass spectrometer. We were able to quantify 5 of the 7 target proteins in depleted plasma digests with reasonable reproducibility over a 2 orders of magnitude linear range (RSD < 25%). The assay panel was utilized for the analysis of a small multiple sclerosis sample cohort with 10 diseased and 8 control patients.
Originalspråkengelska
Sidor (från-till)211-220
TidskriftJournal of Proteomics
Volym75
Utgåva1
DOI
StatusPublished - 2011

Ämnesklassifikation (UKÄ)

  • Medicinteknik

Fingeravtryck

Utforska forskningsämnen för ”MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här